The FDA and CDC recommended a pause for Ixchiq, a chikungunya vaccine, following reports of adverse events in recipients 60 ...

TUESDAY, May 13, 2025 (HealthDay News) — U.S. health officials are telling travelers aged 60 and older to avoid a chikungunya ...

The Trump administration's FDA and CDC is advising U.S. patients using the drug Ixchiq to hold off while U.S. health ...

The U.S. government is advising that international travelers age 60 and older not get a chikungunya vaccine as it ...

A recent Kaiser Family Foundation poll found that fewer than half of Americans trust the government to respond to outbreaks, ...

A study of more than one million people found the shingles vaccine may lower the risk of heart disease and stroke for up to ...

A new study suggests the shingles vaccine may reduce the risk of heart disease for up to eight years post-vaccination. A ...

Vaccine maker Novavax is seeking to convert the 2022 emergency authorization of its Covid-19 vaccine into full approval. Yet ...

In this study, those who had the Zostavax vaccine had a 3.5% point reduction in a new dementia diagnosis over seven years, ...

The CDC began recommending Ixchiq last year for adults traveling to countries where chikungunya is common. The vaccine uses a ...

People who receive the shingles vaccine have a 23% lower risk of cardiovascular events, such as stroke, and coronary heart ...

The shingles vaccine has benefits that stretch beyond protecting older adults from the painful skin condition, a new study ...